Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 77.50
-6.50 (-7.74%)
Oct 7, 2025, 3:16 PM GMT+1
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 31.72 million as of October 7, 2025. Its market cap has increased by 24.44% in one year.
Market Cap
31.72M
Enterprise Value
30.00M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 31.72M, a decrease of -52.66%. That is a compound annual growth rate of -15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 31.72M | 14.29% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.55B |
| Haleon | 29.53B |
| Smith & Nephew | 11.62B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |